共 50 条
- [41] Management of severe immune-related adverse events and outcomes in patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitorsONCOLOGIST, 2024,Naidoo, Jarushka论文数: 0 引用数: 0 h-index: 0机构: RCSI Univ Med & Hlth Sci, Beaumont RCSI Canc Ctr, Dublin, Ireland Beaumont Hosp Dublin, Beaumont RCSI Canc Ctr, Dublin, Ireland Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA RCSI Univ Med & Hlth Sci, Beaumont RCSI Canc Ctr, Dublin, IrelandJohnson, Douglas B.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA RCSI Univ Med & Hlth Sci, Beaumont RCSI Canc Ctr, Dublin, IrelandDoran, Charlotte论文数: 0 引用数: 0 h-index: 0机构: ConcertAI LLC, Cambridge, MA 02138 USA RCSI Univ Med & Hlth Sci, Beaumont RCSI Canc Ctr, Dublin, IrelandWang, Yuexi论文数: 0 引用数: 0 h-index: 0机构: ConcertAI LLC, Cambridge, MA 02138 USA RCSI Univ Med & Hlth Sci, Beaumont RCSI Canc Ctr, Dublin, IrelandZhang, Yan论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ 08540 USA RCSI Univ Med & Hlth Sci, Beaumont RCSI Canc Ctr, Dublin, IrelandLe, Trong Kim论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ 08540 USA RCSI Univ Med & Hlth Sci, Beaumont RCSI Canc Ctr, Dublin, IrelandHopson, Sari论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ 08540 USA RCSI Univ Med & Hlth Sci, Beaumont RCSI Canc Ctr, Dublin, IrelandDreyfus, Brian论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ 08540 USA RCSI Univ Med & Hlth Sci, Beaumont RCSI Canc Ctr, Dublin, IrelandLal, Lincy S.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ 08540 USA RCSI Univ Med & Hlth Sci, Beaumont RCSI Canc Ctr, Dublin, IrelandVyas, Charmy论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ 08540 USA RCSI Univ Med & Hlth Sci, Beaumont RCSI Canc Ctr, Dublin, IrelandGoldstein, Shay论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ 08540 USA RCSI Univ Med & Hlth Sci, Beaumont RCSI Canc Ctr, Dublin, IrelandIzadi, Zara论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ 08540 USA RCSI Univ Med & Hlth Sci, Beaumont RCSI Canc Ctr, Dublin, Ireland
- [42] ASSOCIATION BETWEEN CLINICOPATHOLOGICAL PARAMETERS AND THE EFFICACY OF IMMUNE CHECKPOINT INHIBITOR THERAPY IN PATIENTS WITH BIOPSY-DIAGNOSED NON-SMALL-CELL LUNG CANCERRESPIROLOGY, 2019, 24 : 179 - 180Ota, Takahiro论文数: 0 引用数: 0 h-index: 0机构: Kyoto City Hosp, Resp Med, Kyoto, Japan Kyoto City Hosp, Resp Med, Kyoto, JapanTakada, Naohide论文数: 0 引用数: 0 h-index: 0机构: Kyoto City Hosp, Resp Med, Kyoto, Japan Kyoto City Hosp, Resp Med, Kyoto, JapanNishikawa, Yoshimi论文数: 0 引用数: 0 h-index: 0机构: Kyoto City Hosp, Resp Med, Kyoto, Japan Kyoto City Hosp, Resp Med, Kyoto, JapanYoshioka, Hidetoshi论文数: 0 引用数: 0 h-index: 0机构: Kyoto City Hosp, Resp Med, Kyoto, Japan Kyoto City Hosp, Resp Med, Kyoto, JapanIgarashi, Shuta论文数: 0 引用数: 0 h-index: 0机构: Kyoto City Hosp, Resp Med, Kyoto, Japan Kyoto City Hosp, Resp Med, Kyoto, JapanKobayashi, Yusuke论文数: 0 引用数: 0 h-index: 0机构: Kyoto City Hosp, Resp Med, Kyoto, Japan Kyoto City Hosp, Resp Med, Kyoto, JapanNakamura, Takaya论文数: 0 引用数: 0 h-index: 0机构: Kyoto City Hosp, Resp Med, Kyoto, Japan Kyoto City Hosp, Resp Med, Kyoto, JapanEmura, Masahito论文数: 0 引用数: 0 h-index: 0机构: Kyoto City Hosp, Resp Med, Kyoto, Japan Kyoto City Hosp, Resp Med, Kyoto, Japan
- [43] The association between tumor burden and severe immune-related adverse events in non-small cell lung cancer patients responding to immune-checkpoint inhibitor treatmentLUNG CANCER, 2019, 130 : 159 - 161Sakata, Yoshihiko论文数: 0 引用数: 0 h-index: 0机构: Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, Japan Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, JapanKawamura, Kodai论文数: 0 引用数: 0 h-index: 0机构: Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, Japan Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, JapanIchikado, Kazuya论文数: 0 引用数: 0 h-index: 0机构: Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, Japan Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, JapanShingu, Naoki论文数: 0 引用数: 0 h-index: 0机构: Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, Japan Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, JapanYasuda, Yuko论文数: 0 引用数: 0 h-index: 0机构: Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, Japan Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, JapanEguchi, Yoshitomo论文数: 0 引用数: 0 h-index: 0机构: Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, Japan Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, JapanAnan, Keisuke论文数: 0 引用数: 0 h-index: 0机构: Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, Japan Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, JapanHisanaga, Junpei论文数: 0 引用数: 0 h-index: 0机构: Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, Japan Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, JapanNitawaki, Tatsuya论文数: 0 引用数: 0 h-index: 0机构: Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, Japan Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, JapanIio, Miwa论文数: 0 引用数: 0 h-index: 0机构: Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, Japan Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, JapanSekido, Yuko论文数: 0 引用数: 0 h-index: 0机构: Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, Japan Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, JapanNakan, Aiko论文数: 0 引用数: 0 h-index: 0机构: Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, Japan Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, JapanSakagami, Takuro论文数: 0 引用数: 0 h-index: 0机构: Kumamoto Univ Hosp, Dept Resp Med, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan Saiseikai Kumamoto Hosp, Div Resp Med, 5-3-1 Chikami, Kumamoto 8614193, Japan
- [44] Utomilumab in Patients With Immune Checkpoint Inhibitor-Refractory Melanoma and Non-Small-Cell Lung CancerFRONTIERS IN IMMUNOLOGY, 2022, 13Hong, David S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Div Canc Med, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Div Canc Med, Houston, TX 77030 USAGopal, Ajay K.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Seattle, WA USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Div Canc Med, Houston, TX 77030 USAShoushtari, Alexander N.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Melanoma Serv, Dept Med, 1275 York Ave, New York, NY 10021 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Div Canc Med, Houston, TX 77030 USAPatel, Sandip P.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Div Canc Med, Houston, TX 77030 USAHe, Aiwu R.论文数: 0 引用数: 0 h-index: 0机构: Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Div Canc Med, Houston, TX 77030 USADoi, Toshihiko论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Div Canc Med, Houston, TX 77030 USARamalingam, Suresh S.论文数: 0 引用数: 0 h-index: 0机构: Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Div Canc Med, Houston, TX 77030 USAPatnaik, Amita论文数: 0 引用数: 0 h-index: 0机构: START San Antonio, San Antonio, TX USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Div Canc Med, Houston, TX 77030 USASandhu, Shahneen论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia Univ Melbourne, Melbourne, Vic, Australia Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Div Canc Med, Houston, TX 77030 USAChen, Ying论文数: 0 引用数: 0 h-index: 0机构: Pfizer Oncol, San Diego, CA USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Div Canc Med, Houston, TX 77030 USADavis, Craig B.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Oncol, San Diego, CA USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Div Canc Med, Houston, TX 77030 USAFisher, Timothy S.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Oncol, San Diego, CA USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Div Canc Med, Houston, TX 77030 USAHuang, Bo论文数: 0 引用数: 0 h-index: 0机构: Pfizer Oncol, Groton, CT USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Div Canc Med, Houston, TX 77030 USAFly, Kolette D.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Oncol, Groton, CT USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Div Canc Med, Houston, TX 77030 USARibas, Antoni论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Los Angeles, CA 90024 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Div Canc Med, Houston, TX 77030 USA
- [45] Concomitant Statins and the Survival of Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Meta-AnalysisINTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2022, 2022Zhang, Lei论文数: 0 引用数: 0 h-index: 0机构: Hosp Shunyi Dist Beijing, Dept Oncol, Beijing 101300, Peoples R China Hosp Shunyi Dist Beijing, Dept Oncol, Beijing 101300, Peoples R ChinaWang, Hong论文数: 0 引用数: 0 h-index: 0机构: Hosp Shunyi Dist Beijing, Dept Oncol, Beijing 101300, Peoples R China Hosp Shunyi Dist Beijing, Dept Oncol, Beijing 101300, Peoples R ChinaTian, Jizheng论文数: 0 引用数: 0 h-index: 0机构: Hosp Shunyi Dist Beijing, Dept Oncol, Beijing 101300, Peoples R China Hosp Shunyi Dist Beijing, Dept Oncol, Beijing 101300, Peoples R ChinaSui, Lili论文数: 0 引用数: 0 h-index: 0机构: Hosp Shunyi Dist Beijing, Dept Oncol, Beijing 101300, Peoples R China Hosp Shunyi Dist Beijing, Dept Oncol, Beijing 101300, Peoples R ChinaChen, Xiaoyan论文数: 0 引用数: 0 h-index: 0机构: Hosp Shunyi Dist Beijing, Dept Oncol, Beijing 101300, Peoples R China Hosp Shunyi Dist Beijing, Dept Oncol, Beijing 101300, Peoples R China
- [46] Comments on 'The Impact of Beta Blockers on Survival Outcomes in Patients With Non-small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors'CLINICAL LUNG CANCER, 2022, 23 (03) : E174 - E175Takada, Kazuki论文数: 0 引用数: 0 h-index: 0机构: Saiseikai Fukuoka Gen Hosp, Dept Surg, Fukuoka, Japan Saiseikai Fukuoka Gen Hosp, Dept Surg, Fukuoka, JapanTakamori, Shinkichi论文数: 0 引用数: 0 h-index: 0机构: Natl Hosp Org, Dept Thorac Oncol, Kyushu Canc Ctr, 3-1-1 Notame,Minami Ku, Fukuoka 8111395, Japan Saiseikai Fukuoka Gen Hosp, Dept Surg, Fukuoka, JapanMiura, Naoko论文数: 0 引用数: 0 h-index: 0机构: Saiseikai Fukuoka Gen Hosp, Dept Surg, Fukuoka, Japan Saiseikai Fukuoka Gen Hosp, Dept Surg, Fukuoka, JapanShikada, Yasunori论文数: 0 引用数: 0 h-index: 0机构: Saiseikai Fukuoka Gen Hosp, Dept Surg, Fukuoka, Japan Saiseikai Fukuoka Gen Hosp, Dept Surg, Fukuoka, JapanShimokawa, Mototsugu论文数: 0 引用数: 0 h-index: 0机构: Yamaguchi Univ, Dept Biostat, Grad Sch Med, Yamaguchi, Japan Saiseikai Fukuoka Gen Hosp, Dept Surg, Fukuoka, Japan
- [47] Are we ready for immune checkpoint inhibitors for advanced non-small-cell lung cancer?LANCET, 2016, 387 (10027): : 1488 - 1490Mok, Tony S. K.论文数: 0 引用数: 0 h-index: 0机构: Chinese Univ Hong Kong, State Key Lab Oncol South China, Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China Chinese Univ Hong Kong, State Key Lab Oncol South China, Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R ChinaLoong, Herbert H.论文数: 0 引用数: 0 h-index: 0机构: Chinese Univ Hong Kong, State Key Lab Oncol South China, Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China Chinese Univ Hong Kong, State Key Lab Oncol South China, Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China
- [48] Combing Immune Checkpoint Inhibitors with Radiotherapy in Advanced Non-small-cell Lung CancerJOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S625 - S625Zou, Y.论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Div Thorac Tumor Multimodal Treatment, Ctr Canc, Chengdu, Peoples R China Meishan People Hosp, Dept Oncol, Meishan, Peoples R China Sichuan Univ, West China Hosp, Div Thorac Tumor Multimodal Treatment, Ctr Canc, Chengdu, Peoples R ChinaChen, Y.论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Div Thorac Tumor Multimodal Treatment, Ctr Canc, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Div Thorac Tumor Multimodal Treatment, Ctr Canc, Chengdu, Peoples R ChinaZhou, X.论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Div Thorac Tumor Multimodal Treatment, Ctr Canc, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Div Thorac Tumor Multimodal Treatment, Ctr Canc, Chengdu, Peoples R ChinaGong, Y.论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Div Thorac Tumor Multimodal Treatment, Ctr Canc, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Div Thorac Tumor Multimodal Treatment, Ctr Canc, Chengdu, Peoples R ChinaXu, Y.论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Div Thorac Tumor Multimodal Treatment, Ctr Canc, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Div Thorac Tumor Multimodal Treatment, Ctr Canc, Chengdu, Peoples R ChinaZou, B.论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Div Thorac Tumor Multimodal Treatment, Ctr Canc, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Div Thorac Tumor Multimodal Treatment, Ctr Canc, Chengdu, Peoples R ChinaPeng, F.论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Div Thorac Tumor Multimodal Treatment, Ctr Canc, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Div Thorac Tumor Multimodal Treatment, Ctr Canc, Chengdu, Peoples R ChinaHuang, M.论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Div Thorac Tumor Multimodal Treatment, Ctr Canc, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Div Thorac Tumor Multimodal Treatment, Ctr Canc, Chengdu, Peoples R ChinaLu, Y.论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Div Thorac Tumor Multimodal Treatment, Ctr Canc, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Div Thorac Tumor Multimodal Treatment, Ctr Canc, Chengdu, Peoples R ChinaLiu, Y.论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Div Thorac Tumor Multimodal Treatment, Ctr Canc, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Div Thorac Tumor Multimodal Treatment, Ctr Canc, Chengdu, Peoples R China
- [49] Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancerANNALS OF ONCOLOGY, 2018, 29 (06) : 1437 - 1444Derosa, L.论文数: 0 引用数: 0 h-index: 0机构: GRCC, Villejuif, France INSERM, U1015, Equipe Labellisee Ligue Natl Canc, Villejuif, France Univ Paris Saclay, Univ Paris Sud, Gustave Roussy, Villejuif, France GRCC, Villejuif, FranceHellmann, M. D.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, Thorac Oncol Serv, 1275 York Ave, New York, NY 10021 USA Weill Cornell Med Coll, Dept Med, New York, NY USA Parker Inst Canc Immunotherapy, New York, NY USA GRCC, Villejuif, FranceSpaziano, M.论文数: 0 引用数: 0 h-index: 0机构: McGill Univ, Div Cardiol, Dept Med, Montreal, PQ, Canada GRCC, Villejuif, FranceHalpenny, D.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA GRCC, Villejuif, FranceFidelle, M.论文数: 0 引用数: 0 h-index: 0机构: GRCC, Villejuif, France INSERM, U1015, Equipe Labellisee Ligue Natl Canc, Villejuif, France Univ Paris Saclay, Univ Paris Sud, Gustave Roussy, Villejuif, France GRCC, Villejuif, FranceRizvi, H.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Druckenmiller Ctr Lung Canc Res, 1275 York Ave, New York, NY 10021 USA GRCC, Villejuif, FranceLong, N.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA GRCC, Villejuif, FrancePlodkowski, A. J.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA GRCC, Villejuif, FranceArbour, K. C.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, Thorac Oncol Serv, 1275 York Ave, New York, NY 10021 USA GRCC, Villejuif, FranceChaft, J. E.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, Thorac Oncol Serv, 1275 York Ave, New York, NY 10021 USA Weill Cornell Med Coll, Dept Med, New York, NY USA GRCC, Villejuif, FranceRouche, J. A.论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Dept Imaging, Villejuif, France GRCC, Villejuif, FranceZitvogel, L.论文数: 0 引用数: 0 h-index: 0机构: GRCC, Villejuif, France INSERM, U1015, Equipe Labellisee Ligue Natl Canc, Villejuif, France Univ Paris Saclay, Univ Paris Sud, Gustave Roussy, Villejuif, France Ctr Clin Invest Biotherapies Canc CICBT 1428, Villejuif, France GRCC, Villejuif, FranceZalcman, G.论文数: 0 引用数: 0 h-index: 0机构: Univ Paris Diderot, Hosp Bichat Claude Bernard, AP HP, Thorac Oncol Dept,CIC1425,Paris Nord CLIP2, Paris, France GRCC, Villejuif, FranceAlbiges, L.论文数: 0 引用数: 0 h-index: 0机构: GRCC, Villejuif, France Univ Paris Saclay, Univ Paris Sud, Gustave Roussy, Villejuif, France Gustave Roussy, Dept Med Oncol, Villejuif, France GRCC, Immunol Integrat Tumeurs & Genet Oncol, Villejuif, France GRCC, Villejuif, FranceEscudier, B.论文数: 0 引用数: 0 h-index: 0机构: GRCC, Villejuif, France Gustave Roussy, Dept Med Oncol, Villejuif, France GRCC, Immunol Integrat Tumeurs & Genet Oncol, Villejuif, France GRCC, Villejuif, FranceRouty, B.论文数: 0 引用数: 0 h-index: 0机构: GRCC, Villejuif, France INSERM, U1015, Equipe Labellisee Ligue Natl Canc, Villejuif, France Univ Paris Saclay, Univ Paris Sud, Gustave Roussy, Villejuif, France CHUM, Dept Med, Hematol Oncol Div, Montreal, PQ, Canada CRCHUM, 900 St Denis St R10-474, Montreal, PQ H2X 0A9, Canada GRCC, Villejuif, France
- [50] A systems pathology model for predicting overall survival in patients with refractory, advanced non-small-cell lung cancer treated with gefitinibEUROPEAN JOURNAL OF CANCER, 2009, 45 (08) : 1518 - 1526Donovan, Michael J.论文数: 0 引用数: 0 h-index: 0机构: Aureon Labs, Yonkers, NY 10701 USA Aureon Labs, Yonkers, NY 10701 USAKotsianti, Angeliki论文数: 0 引用数: 0 h-index: 0机构: Aureon Labs, Yonkers, NY 10701 USA Aureon Labs, Yonkers, NY 10701 USABayer-Zubek, Valentina论文数: 0 引用数: 0 h-index: 0机构: Aureon Labs, Yonkers, NY 10701 USA Aureon Labs, Yonkers, NY 10701 USAVerbel, David论文数: 0 引用数: 0 h-index: 0机构: Aureon Labs, Yonkers, NY 10701 USA Aureon Labs, Yonkers, NY 10701 USATeverovskiy, Mikhail论文数: 0 引用数: 0 h-index: 0机构: Aureon Labs, Yonkers, NY 10701 USA Aureon Labs, Yonkers, NY 10701 USACordon-Cardo, Carlos论文数: 0 引用数: 0 h-index: 0机构: Aureon Labs, Yonkers, NY 10701 USA Columbia Univ, New York, NY 10027 USA Aureon Labs, Yonkers, NY 10701 USACosta, Jose论文数: 0 引用数: 0 h-index: 0机构: Aureon Labs, Yonkers, NY 10701 USA Yale Univ, Sch Med, New Haven, CT USA Aureon Labs, Yonkers, NY 10701 USAGreco, F. Anthony论文数: 0 引用数: 0 h-index: 0机构: Sarah Cannon Canc Ctr, Nashville, TN USA Aureon Labs, Yonkers, NY 10701 USAHainsworth, John D.论文数: 0 引用数: 0 h-index: 0机构: Sarah Cannon Canc Ctr, Nashville, TN USA Aureon Labs, Yonkers, NY 10701 USAParums, Dinah V.论文数: 0 引用数: 0 h-index: 0机构: Aureon Labs, Yonkers, NY 10701 USA